We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$309M
Cap. Flow
+$259M
Cap. Flow %
17.55%
Top 10 Hldgs %
27.29%
Holding
179
New
33
Increased
51
Reduced
54
Closed
39

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$58.8M
2
LYFT icon
Lyft
LYFT
+$27.4M
3
CLVT icon
Clarivate
CLVT
+$26.3M
4
FTDR icon
Frontdoor
FTDR
+$24.5M
5
CRM icon
Salesforce
CRM
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 31.82%
2 Consumer Discretionary 14.98%
3 Communication Services 13.53%
4 Healthcare 8.23%
5 Industrials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRN icon
26
Stride
LRN
$3.43B
$15.9M 1.08%
509,403
+394,200
+342% +$14.5M
BKNG icon
27
Booking.com
BKNG
$161B
$15.8M 1.08%
196,600
-71,200
-27% -$5.41M
PYPL icon
28
PayPal
PYPL
$50.5B
$15.8M 1.07%
+221,964
New +$17.8M
WKC icon
29
World Kinect Corp
WKC
$1.86B
$15.8M 1.07%
576,770
-196,784
-25% -$5.29M
EXEL icon
30
Exelixis
EXEL
$13.4B
$15.5M 1.05%
+964,087
New +$15.7M
NOMD icon
31
Nomad Foods
NOMD
$1.68B
$14.8M 1.01%
860,577
-475,255
-36% -$7.53M
SMAR
32
DELISTED
Smartsheet Inc.
SMAR
$14.7M 1%
+374,322
New +$12.8M
META icon
33
Meta Platforms (Facebook)
META
$1.51T
$13.6M 0.92%
112,989
-77,900
-41% -$9.15M
BLCO icon
34
Bausch + Lomb
BLCO
$5.99B
$13.6M 0.92%
876,374
+295,510
+51% +$4.44M
VZ icon
35
Verizon
VZ
$196B
$13M 0.88%
329,500
+19,206
+6% +$724K
INTC icon
36
Intel
INTC
$513B
$12.9M 0.88%
488,949
+216,804
+80% +$6.02M
CNC icon
37
Centene
CNC
$32.5B
$12.9M 0.87%
+157,152
New +$12.8M
EXFY icon
38
Expensify
EXFY
$245M
$12.7M 0.86%
+1,436,358
New +$16.1M
HSII
39
DELISTED
Heidrick & Struggles
HSII
$12.5M 0.85%
448,534
+1,157
+0.3% +$32.7K
OC icon
40
Owens Corning
OC
$12.4B
$12.3M 0.84%
144,347
+16,452
+13% +$1.44M
HRT
41
DELISTED
HireRight Holdings Corporation
HRT
$12M 0.81%
1,011,367
+97,348
+11% +$1.21M
NVEI
42
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$11.9M 0.81%
468,270
-23,583
-5% -$668K
CHRD icon
43
Chord Energy
CHRD
$7.39B
$11.5M 0.78%
83,991
+19,235
+30% +$2.82M
BTG icon
44
B2Gold
BTG
$6.64B
$11.1M 0.75%
3,122,620
+1,532,711
+96% +$5.1M
KGC icon
45
Kinross Gold
KGC
$32.8B
$11M 0.75%
2,686,702
+991,383
+58% +$3.92M
IMMR icon
46
Immersion
IMMR
$252M
$10.8M 0.73%
1,534,323
-134,838
-8% -$868K
TTE icon
47
TotalEnergies
TTE
$190B
$10.5M 0.72%
169,816
-61,499
-27% -$3.51M
EXPE icon
48
Expedia Group
EXPE
$37.3B
$10.5M 0.71%
119,863
+58,295
+95% +$5.51M
MDT icon
49
Medtronic
MDT
$112B
$10.5M 0.71%
+134,517
New +$10.9M
BPOP icon
50
Popular Inc
BPOP
$11.1B
$10.4M 0.71%
156,910
-160,269
-51% -$11.1M

Similar funds

Invenomic Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Invenomic Capital Management held 179 positions worth $1.47B, up 27% from $1.16B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $259M of net new capital in Q4 2022, opening 33 new positions and adding to 51 existing holdings. Its largest new stake was Clarivate: 2,805,166 shares worth $23.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Universal Health Services, an estimated $22.3M trimmed.

  • Invenomic Capital Management's largest Q4 2022 buy was Clarivate: 2,805,166 shares worth $23.4M.
  • Invenomic Capital Management added most to Applovin in Q4 2022, an estimated $58.8M increase.
  • Invenomic Capital Management's biggest Q4 2022 reduction was Universal Health Services, cutting an estimated $22.3M.
  • Invenomic Capital Management fully exited Cisco in Q4 2022, selling an estimated $27.1M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $1.47B portfolio in Q4 2022.
  • Invenomic Capital Management opened 33 new positions and closed 39 in Q4 2022.
  • Invenomic Capital Management's portfolio value rose 27% quarter-over-quarter to $1.47B.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.